CVS Stock Jumps On Plans to Expand a New Store Format
CVS stock is leading the healthcare sector higher after CVS Health Corp (NYSE:CVS) revealed a range of major new offerings at its stores.
Expanding Strategy
Access to quality healthcare is one of the …
Johnson & Johnson Investigation: Shares Fall Again Over Asbestos
Another Johnson & Johnson investigation (NYSE:JNJ) is underway, and JNJ shares have taken a nosedive in response. Once again, the company is being investigated for asbestos contamination.
JNJ shares dived from $136.39 USD …
CVS Health Launches its Pilot Membership Program in Boston and Its Stock Jumps
CVS Health Corporation (NYSE:CVS), also known as CVS Pharmacy, just announced that customers in the Greater Boston area can enroll in CarePass. CarePass is CVS’s new pilot membership program that adds to its popular ExtraCare …
Clovis Oncology Gets FDA Approval for Ovarian Cancer Treatment
Colorado-based biopharmaceutical company, Clovis Oncology (Nasdaq:CLVS) has received approval from the United States Food and Drug Administration (FDA) today for the company’s ovarian cancer maintenance treatment, RUBRACA (rucaparib).
RUBRACA, which is available in …
Incyte Corporation Stock Takes a Nose Dive After Drug Trial Failure
Stock of the biotechnology company Incyte Corporation (Nasdaq:INCY) have taken a nosedive today after the company released the failed results of their cancer research Phase 3 ECHO-301/KEYNOTE-252 study.
>>>Auris Health – Monarch Platform …
Opioids Prescribed Less in States where Medical Marijuana is Legal
Two studies, from the University of Georgia and the University of Kentucky, found that in states where medical marijuana is legal, there was a smaller prescription rate of opioids.
The study from the …
CVS to Purchase Healthcare Insurance Company Aetna
Breaking news: drugstore chain CVS Health (NYSE:CVS) is purchasing healthcare insurance behemoth Aetna (NYSE:AET).
If the proposed deal, which was announced Sunday, is approved, the $69 billion acquisition would wholeheartedly revamp the healthcare …
Glaukos Corp Lowers Revenue Expectation, 16-Quarter Streak Coming to an End?
Glaukos Corp. (NASDAQ:$GKOS) is a medical device manufacturer with an eye on glaucoma. The company’s shares are plundering 16.7% today, after management made some adjustments to this year’s total revenue expectations.
The company’s …
Lung Disease Drug Sends Insmed’s Stock Soaring
As of pre-market trading Tuesday, shares of Insmed Inc. (NASDAQ:$ INSM) more than doubled. This came after the company announced that its new drug, an inhaled antibiotic known as Alis, successfully treated patients with a …
Shares of Drug Manufacturer Perrigo Co. Increase After Q2 Profit and Revenue Beats
If you’re looking for a drug manufacturer to invest in, you should know that Perrigo Company plc (NYSE:$PRGO) saw its shares increase 12.2% in pre-market trade today. Why? It all started after the company posted …